{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:46:42Z","timestamp":1789019202013,"version":"build-2803163510"},"reference-count":92,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.hoc.2021.08.006","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T11:54:46Z","timestamp":1635162886000},"page":"77-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Update on Radiation Therapy for Central Nervous System Tumors"],"prefix":"10.1016","volume":"36","author":[{"given":"Rifaquat","family":"Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Sulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne","family":"Haas-Kogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel N.","family":"Cagney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.hoc.2021.08.006_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.hoc.2019.08.015","article-title":"Current role of radiation therapy in the management of malignant central nervous system tumors","volume":"34","author":"Farooqi","year":"2020","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.hoc.2021.08.006_bib2","series-title":"Radiobiology for the radiologist","author":"Hall","year":"2012"},{"issue":"1","key":"10.1016\/j.hoc.2021.08.006_bib3","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3390\/ijms17010102","article-title":"Cellular pathways in response to ionizing radiation and their targetability for tumor radiosensitization","volume":"17","author":"Maier","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"15","key":"10.1016\/j.hoc.2021.08.006_bib4","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1007\/s00018-016-2130-4","article-title":"The DNA damage-induced cell death response: a roadmap to kill cancer cells","volume":"73","author":"Matt","year":"2016","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"10.1016\/j.hoc.2021.08.006_bib5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11910-020-01051-5","article-title":"Neurologic complications of cranial radiation therapy and strategies to prevent or reduce radiation toxicity","volume":"20","author":"Rahman","year":"2020","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"4","key":"10.1016\/j.hoc.2021.08.006_bib6","first-page":"316","article-title":"The stereotaxic method and radiosurgery of the brain","volume":"102","author":"Leksell","year":"1951","journal-title":"Acta Chir Scand"},{"issue":"2","key":"10.1016\/j.hoc.2021.08.006_bib7","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijrobp.2009.09.042","article-title":"American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy","volume":"76","author":"Potters","year":"2010","journal-title":"Int J Radiat Oncol"},{"issue":"suppl_2","key":"10.1016\/j.hoc.2021.08.006_bib8","doi-asserted-by":"crossref","first-page":"ii38","DOI":"10.1093\/neuonc\/now301","article-title":"The radiosurgery fractionation quandary: single fraction or hypofractionation?","volume":"19","author":"Kirkpatrick","year":"2017","journal-title":"Neuro Oncol"},{"issue":"5","key":"10.1016\/j.hoc.2021.08.006_bib9","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/neuros\/nyy454","article-title":"The promise of proton therapy for central nervous system malignancies","volume":"84","author":"Vogel","year":"2019","journal-title":"Neurosurgery"},{"issue":"12 Suppl 2","key":"10.1016\/j.hoc.2021.08.006_bib10","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noaa200","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013-2017","volume":"22","author":"Ostrom","year":"2020","journal-title":"Neuro-Oncol"},{"issue":"6","key":"10.1016\/j.hoc.2021.08.006_bib11","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol (Berl)"},{"issue":"8","key":"10.1016\/j.hoc.2021.08.006_bib12","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.hoc.2021.08.006_bib13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1200\/JCO.2012.43.2674","article-title":"Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402","volume":"31","author":"Cairncross","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.hoc.2021.08.006_bib14","first-page":"333","article-title":"Evaluation of BCNU and\/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial","volume":"49","author":"Walker","year":"1978","journal-title":"J\u00a0Neurosurg"},{"issue":"23","key":"10.1016\/j.hoc.2021.08.006_bib15","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1056\/NEJM198012043032303","article-title":"Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery","volume":"303","author":"Walker","year":"1980","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.hoc.2021.08.006_bib16","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/1097-0142(19810215)47:4<649::AID-CNCR2820470405>3.0.CO;2-W","article-title":"Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group","volume":"47","author":"Kristiansen","year":"1981","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.hoc.2021.08.006_bib17","first-page":"1","article-title":"Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001","volume":"71","author":"Shapiro","year":"1989","journal-title":"J\u00a0Neurosurg"},{"issue":"10","key":"10.1016\/j.hoc.2021.08.006_bib18","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/0360-3016(79)90553-4","article-title":"An analysis of dose-effect relationship in the radiotherapy of malignant gliomas","volume":"5","author":"Walker","year":"1979","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.hoc.2021.08.006_bib19","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.hoc.2021.08.006_bib20","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol"},{"issue":"23","key":"10.1016\/j.hoc.2021.08.006_bib21","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1001\/jama.2017.18718","article-title":"Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial","volume":"318","author":"Stupp","year":"2017","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.hoc.2021.08.006_bib22","first-page":"279","article-title":"Combined modality approach to treatment of malignant gliomas--re-evaluation of RTOG 7401\/ECOG 1374 with long-term follow-up: a joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group","author":"Nelson","year":"1988","journal-title":"NCI Monogr Publ Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.hoc.2021.08.006_bib23","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1200\/JCO.2002.20.6.1635","article-title":"Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy","volume":"20","author":"Chan","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.hoc.2021.08.006_bib24","first-page":"251","article-title":"Accelerated fractionated proton\/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial","volume":"91","author":"Fitzek","year":"1999","journal-title":"J\u00a0Neurosurg"},{"issue":"1","key":"10.1016\/j.hoc.2021.08.006_bib25","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijrobp.2009.04.054","article-title":"Phase I\/II trial of hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme","volume":"77","author":"Mizumoto","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.hoc.2021.08.006_bib26","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11060-013-1139-x","article-title":"Immediate post-operative brachytherapy prior to irradiation and temozolomide for newly diagnosed glioblastoma","volume":"113","author":"Waters","year":"2013","journal-title":"J\u00a0Neurooncol"},{"issue":"3","key":"10.1016\/j.hoc.2021.08.006_bib27","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.ijrobp.2004.04.011","article-title":"Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol","volume":"60","author":"Souhami","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.hoc.2021.08.006_bib28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0360-3016(92)91021-E","article-title":"Supratentorial malignant glioma: patterns of recurrence and implications for external beam local treatment","volume":"24","author":"Gaspar","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.hoc.2021.08.006_bib29","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.radonc.2010.08.020","article-title":"Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide","volume":"97","author":"Minniti","year":"2010","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2021.08.006_bib30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.radonc.2015.12.003","article-title":"ESTRO-ACROP guideline \u201ctarget delineation of glioblastomas\u201d","volume":"118","author":"Niyazi","year":"2016","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2021.08.006_bib31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11060-019-03152-9","article-title":"NRG brain tumor specialists consensus guidelines for glioblastoma contouring","volume":"143","author":"Kruser","year":"2019","journal-title":"J\u00a0Neurooncol"},{"issue":"1","key":"10.1016\/j.hoc.2021.08.006_bib32","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijrobp.2009.10.048","article-title":"Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma","volume":"79","author":"McDonald","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hoc.2021.08.006_bib33","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1748-717X-9-130","article-title":"Patterns of failure for glioblastoma multiforme following limited-margin radiation and concurrent temozolomide","volume":"9","author":"Gebhardt","year":"2014","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2021.08.006_bib34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ijrobp.2018.01.069","article-title":"Effect of radiation treatment volume reduction on lymphopenia in patients receiving chemoradiotherapy for glioblastoma","volume":"101","author":"Rudra","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hoc.2021.08.006_bib35","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noaa111","article-title":"A\u00a0quantitative framework for modeling COVID-19 risk during adjuvant therapy using published randomized trials of glioblastoma in the elderly","author":"Tabrizi","year":"2020","journal-title":"Neuro Oncol"},{"issue":"9","key":"10.1016\/j.hoc.2021.08.006_bib36","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1200\/JCO.2004.06.082","article-title":"Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial","volume":"22","author":"Roa","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.hoc.2021.08.006_bib37","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMoa1611977","article-title":"Short-course radiation plus temozolomide in elderly patients with glioblastoma","volume":"376","author":"Perry","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.hoc.2021.08.006_bib38","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S1470-2045(12)70164-X","article-title":"Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial","volume":"13","author":"Wick","year":"2012","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.hoc.2021.08.006_bib39","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S1470-2045(12)70265-6","article-title":"Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial","volume":"13","author":"Malmstr\u00f6m","year":"2012","journal-title":"Lancet Oncol"},{"issue":"35","key":"10.1016\/j.hoc.2021.08.006_bib40","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1200\/JCO.2015.62.6606","article-title":"International atomic energy agency randomized phase III study of radiation therapy in elderly and\/or frail patients with newly diagnosed glioblastoma multiforme","volume":"33","author":"Roa","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.hoc.2021.08.006_bib41","first-page":"1529","article-title":"Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide","volume":"18","author":"Wick","year":"2016","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.hoc.2021.08.006_bib42","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noaa215.196","article-title":"CODEL: phase III study of RT, RT\u2009+ TMZ, or TMZ for newly diagnosed 1p\/19q codeleted oligodendroglioma. Analysis from the initial study design","author":"Jaeckle","year":"2020","journal-title":"Neuro Oncol"},{"issue":"10103","key":"10.1016\/j.hoc.2021.08.006_bib43","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/S0140-6736(17)31442-3","article-title":"Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p\/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study","volume":"390","author":"van den Bent","year":"2017","journal-title":"Lancet"},{"issue":"15_suppl","key":"10.1016\/j.hoc.2021.08.006_bib44","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1200\/JCO.2019.37.15_suppl.2000","article-title":"Second interim and first molecular analysis of the EORTC randomized phase III intergroup CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p\/19q codeletion","volume":"37","author":"Van Den Bent","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.hoc.2021.08.006_bib45","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1200\/JCO.2012.43.2229","article-title":"Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951","volume":"31","author":"van den Bent","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"9490","key":"10.1016\/j.hoc.2021.08.006_bib46","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0140-6736(05)67070-5","article-title":"Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial","volume":"366","author":"van den Bent","year":"2005","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.hoc.2021.08.006_bib47","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0360-3016(96)00352-5","article-title":"A\u00a0randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844","volume":"36","author":"Karim","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.hoc.2021.08.006_bib48","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1200\/JCO.2002.09.126","article-title":"Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group\/Radiation Therapy Oncology Group\/Eastern Cooperative Oncology Group study","volume":"20","author":"Shaw","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"issue":"29","key":"10.1016\/j.hoc.2021.08.006_bib49","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1200\/JCO.19.02983","article-title":"Comprehensive genomic analysis in NRG oncology\/RTOG 9802: a phase III trial of radiation versus radiation plus procarbazine, lomustine (CCNU), and vincristine in high-risk low-grade glioma","volume":"38","author":"Bell","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.hoc.2021.08.006_bib50","first-page":"835","article-title":"Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial","volume":"109","author":"Shaw","year":"2008","journal-title":"J\u00a0Neurosurg"},{"issue":"1","key":"10.1016\/j.hoc.2021.08.006_bib51","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11912-011-0203-y","article-title":"Epidemiology of brain metastases","volume":"14","author":"Nayak","year":"2012","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.hoc.2021.08.006_bib52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000331167","article-title":"Epidemiology of central nervous system metastases","volume":"25","author":"Alexandru","year":"2012","journal-title":"Prog Neurol Surg"},{"issue":"14","key":"10.1016\/j.hoc.2021.08.006_bib53","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1200\/JCO.2004.12.149","article-title":"Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System","volume":"22","author":"Barnholtz-Sloan","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.hoc.2021.08.006_bib54","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/neuonc\/nox077","article-title":"Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study","volume":"19","author":"Cagney","year":"2017","journal-title":"Neuro-Oncol"},{"issue":"10","key":"10.1016\/j.hoc.2021.08.006_bib55","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1002\/cncr.10541","article-title":"Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma","volume":"94","author":"Schouten","year":"2002","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.hoc.2021.08.006_bib56","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41571-019-0320-3","article-title":"Current approaches to the management of brain metastases","volume":"17","author":"Suh","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.hoc.2021.08.006_bib57","doi-asserted-by":"crossref","first-page":"67","DOI":"10.14694\/EdBook_AM.2015.35.67","article-title":"Targeted and immunotherapeutic approaches in brain metastases","author":"Ahluwalia","year":"2015","journal-title":"Am Soc Clin Oncol Educ Book Am Soc Clin Oncol Annu Meet"},{"issue":"1","key":"10.1016\/j.hoc.2021.08.006_bib58","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41572-018-0055-y","article-title":"Brain metastases","volume":"5","author":"Achrol","year":"2019","journal-title":"Nat Rev Dis Primer"},{"issue":"3","key":"10.1016\/j.hoc.2021.08.006_bib59","doi-asserted-by":"crossref","first-page":"E152","DOI":"10.1093\/neuros\/nyy542","article-title":"Congress of neurological surgeons systematic review and evidence-based guidelines on the role of surgery in the management of adults with metastatic brain tumors","volume":"84","author":"Nahed","year":"2019","journal-title":"Neurosurgery"},{"issue":"3","key":"10.1016\/j.hoc.2021.08.006_bib60","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/neuros\/nyx522","article-title":"Stereotactic Radiosurgery in the Management of Limited (1-4) brain metasteses: systematic review and international stereotactic radiosurgery society practice guideline","volume":"83","author":"Chao","year":"2018","journal-title":"Neurosurgery"},{"key":"10.1016\/j.hoc.2021.08.006_bib61","article-title":"Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases","volume":"1","author":"Tsao","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.hoc.2021.08.006_bib62","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1200\/JCO.2010.29.6053","article-title":"Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis","volume":"29","author":"Sun","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.hoc.2021.08.006_bib63","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S1470-2045(17)30441-2","article-title":"Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C\/CEC\u00b73): a multicentre, randomised, controlled, phase 3 trial","volume":"18","author":"Brown","year":"2017","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2021.08.006_bib64","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijrobp.2007.09.059","article-title":"Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis","volume":"71","author":"Li","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.hoc.2021.08.006_bib65","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1200\/JCO.2011.41.0639","volume":"31","author":"Soffietti","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"10055","key":"10.1016\/j.hoc.2021.08.006_bib66","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/S0140-6736(16)30825-X","volume":"388","author":"Mulvenna","year":"2016","journal-title":"Lancet"},{"issue":"34","key":"10.1016\/j.hoc.2021.08.006_bib67","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1200\/JCO.2014.57.2909","article-title":"Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial","volume":"32","author":"Gondi","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"15_suppl","key":"10.1016\/j.hoc.2021.08.006_bib68","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1200\/JCO.2019.37.15_suppl.2009","article-title":"NRG Oncology CC001: a phase III trial of hippocampal avoidance (HA) in addition to whole-brain radiotherapy (WBRT) plus memantine to preserve neurocognitive function (NCF) in patients with brain metastases (BM)","volume":"37","author":"Gondi","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.hoc.2021.08.006_bib69","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1200\/JCO.19.02767","article-title":"Hippocampal avoidance during whole-brain radiotherapy plus memantine for patients with brain metastases: phase III trial NRG Oncology CC001","volume":"38","author":"Brown","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.hoc.2021.08.006_bib70","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1200\/JCO.19.03359","article-title":"Neurocognitive outcomes for patients with brain metastasis in the modern era: benefit of treatment with hippocampal avoidance whole-brain radiotherapy plus memantine","volume":"38","author":"Weiner","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.hoc.2021.08.006_bib71","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/neuonc\/not114","article-title":"Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial","volume":"15","author":"Brown","year":"2013","journal-title":"Neuro Oncol"},{"issue":"15","key":"10.1016\/j.hoc.2021.08.006_bib72","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1200\/JCO.2014.58.4508","article-title":"Donepezil for irradiated brain tumor survivors: a phase III randomized placebo-controlled clinical trial","volume":"33","author":"Rapp","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"21","key":"10.1016\/j.hoc.2021.08.006_bib73","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1001\/jama.295.21.2483","article-title":"Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial","volume":"295","author":"Aoyama","year":"2006","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.hoc.2021.08.006_bib74","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jama.2016.9839","article-title":"Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial","volume":"316","author":"Brown","year":"2016","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.hoc.2021.08.006_bib75","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1001\/jamaoncol.2015.1145","article-title":"Stereotactic radiosurgery with or without whole-brain radiotherapy for brain metastases: secondary analysis of the JROSG 99-1 randomized clinical trial","volume":"1","author":"Aoyama","year":"2015","journal-title":"JAMA Oncol"},{"issue":"9422","key":"10.1016\/j.hoc.2021.08.006_bib76","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(04)16250-8","article-title":"Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial","volume":"363","author":"Andrews","year":"2004","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.hoc.2021.08.006_bib77","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S1470-2045(17)30414-X","article-title":"Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial","volume":"18","author":"Mahajan","year":"2017","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.hoc.2021.08.006_bib78","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0360-3016(99)00507-6","article-title":"Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05","volume":"47","author":"Shaw","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.hoc.2021.08.006_bib79","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ijrobp.2017.09.047","article-title":"Consensus contouring guidelines for postoperative completely resected cavity stereotactic radiosurgery for brain metastases","volume":"100","author":"Soliman","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.hoc.2021.08.006_bib80","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1001\/jamaoncol.2018.7204","article-title":"Association of neurosurgical resection with development of pachymeningeal seeding in patients with brain metastases","volume":"5","author":"Cagney","year":"2019","journal-title":"JAMA Oncol"},{"issue":"8","key":"10.1016\/j.hoc.2021.08.006_bib81","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/neuonc\/noz049","article-title":"A\u00a0multi-institutional analysis of presentation and outcomes for leptomeningeal disease recurrence after surgical resection and radiosurgery for brain metastases","volume":"21","author":"Prabhu","year":"2019","journal-title":"Neuro Oncol"},{"issue":"suppl_4","key":"10.1016\/j.hoc.2021.08.006_bib82","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015","volume":"20","author":"Ostrom","year":"2018","journal-title":"Neuro Oncol"},{"issue":"3","key":"10.1016\/j.hoc.2021.08.006_bib83","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/1097-0142(19930801)72:3<639::AID-CNCR2820720304>3.0.CO;2-P","article-title":"Epidemiology of intracranial meningioma","volume":"72","author":"Longstreth","year":"1993","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.hoc.2021.08.006_bib84","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/neuonc\/nos208","article-title":"Ionizing radiation and the risk of brain and central nervous system tumors: a systematic review","volume":"14","author":"Braganza","year":"2012","journal-title":"Neuro Oncol"},{"issue":"3","key":"10.1016\/j.hoc.2021.08.006_bib85","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/bpa.12174","article-title":"Mitotic index is an independent predictor of recurrence-free survival in Meningioma","volume":"25","author":"Olar","year":"2015","journal-title":"Brain Pathol Zurich Switz"},{"issue":"Suppl 1","key":"10.1016\/j.hoc.2021.08.006_bib86","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.21037\/cco.2017.06.10","article-title":"Current and emerging principles in surgery for meningioma","volume":"6","author":"Bi","year":"2017","journal-title":"Chin Clin Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2021.08.006_bib87","first-page":"35","article-title":"Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539","volume":"129","author":"Rogers","year":"2018","journal-title":"J\u00a0Neurosurg"},{"issue":"4","key":"10.1016\/j.hoc.2021.08.006_bib88","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.ijrobp.2019.11.028","article-title":"High-risk meningioma: initial outcomes from NRG Oncology\/RTOG 0539","volume":"106","author":"Rogers","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hoc.2021.08.006_bib89","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.wneu.2019.06.064","article-title":"Stereotactic radiosurgery in large intracranial meningiomas: a systematic review","volume":"129","author":"Fatima","year":"2019","journal-title":"World Neurosurg"},{"issue":"4","key":"10.1016\/j.hoc.2021.08.006_bib90","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.nec.2013.05.006","article-title":"Stereotactic radiosurgery of intracranial meningiomas","volume":"24","author":"Pollock","year":"2013","journal-title":"Neurosurg Clin N Am"},{"issue":"6","key":"10.1016\/j.hoc.2021.08.006_bib91","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.3171\/2019.3.FOCUS1970","article-title":"Stereotactic radiosurgery versus stereotactic radiotherapy in the management of intracranial meningiomas: a systematic review and meta-analysis","volume":"46","author":"Fatima","year":"2019","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.hoc.2021.08.006_bib92","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1186\/s13063-015-1040-3","article-title":"The ROAM\/EORTC-1308 trial: radiation versus observation following surgical resection of Atypical Meningioma: study protocol for a randomised controlled trial","volume":"16","author":"Jenkinson","year":"2015","journal-title":"Trials"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985882100109X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985882100109X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:18:35Z","timestamp":1760185115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088985882100109X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S088985882100109X"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2021.08.006","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on Radiation Therapy for Central Nervous System Tumors","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2021.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}